Onconetics Pharmaceuticals Overview

  • Founded
  • 2016
Founded
  • Status
  • Out of Business
  • Employees
  • 3
Employees
  • Latest Deal Type
  • Out of Business

Onconetics Pharmaceuticals General Information

Description

Developer of a therapeutic platform designed to facilitate personalized gene therapies for cancer. The company's platform utilizes a genetic switch that activates an apoptotic inducer to kill the cancer cell and spares healthy tissue, enabling physicians to target tumor cells with specific gene expression profiles.

Contact Information

Website
www.onconetics.com
Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Primary Office
  • 130 Cascade Drivenmill
  • Mill Valley, CA 94941
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Onconetics Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 20-Feb-2022 00000 Completed Out of Business
1. Accelerator/Incubator 05-Oct-2017 00000 00000 00.00 Completed Generating Revenue
To view Onconetics Pharmaceuticals’s complete valuation and funding history, request access »

Onconetics Pharmaceuticals Patents

  • 3

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 000

    Granted

  • 2

    Pending

  • 000

    Expiring in next 12 mo

Onconetics Pharmaceuticals Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3874041-A1 Multi-component vector systems, methods of making, and uses thereof Pending 01-Nov-2018 0000000000
EP-3774857-A1 Microrna regulated expression vectors, methods of making, and uses thereof Pending 10-Apr-2018 000000000
US-20210095310-A1 Microrna regulated expression vectors, methods of making, and uses thereof Pending 10-Apr-2018 C12N15/85

Onconetics Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial